Lorena Urda

Hauser, D., Urda, L., Lang, C., Mittelholzer, C., Otte, F., Kipfer, E., Zhang, Y., Lett, M., Schebitz, C., Müller, R.-U., Klimkait, W., & Klimkait, T. (2024). Benefits of Repeated SARS-CoV-2 Vaccination and Virus-induced Cross-neutralization Potential in Immunocompromised Transplant Patients and Healthy Individuals [Journal-article]. Open Forum Infectious Diseases, 11(10). https://doi.org/10.1093/ofid/ofae527

Kipfer, E. T., Hauser, D., Lett, M. J., Otte, F., Urda, L., Zhang, Y., Lang, C. M. R., Chami, M., Mittelholzer, C., & Klimkait, T. (2023). Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform. eLife, 12. https://doi.org/10.7554/eLife.89035

Kipfer, E. T., Hauser, D., Lett, M. J., Otte, F., Urda, L., Zhang, Y., Lang, C. M., Chami, M., Mittelholzer, C., & Klimkait, T. (2023). Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform [Journal-article]. eLife, 12. https://doi.org/10.7554/elife.89035.3

Seeburg, U., Urda, L., Otte, F., Lett, M. J., Caimi, S., Mittelholzer, C., & Klimkait, T. (2023). Virus Inactivation by Formaldehyde and Common Lysis Buffers. Viruses, 15(8). https://doi.org/10.3390/v15081693

Brown, Jennifer A., Nsakala, Bienvenu L., Mokhele, Kuena, Rakuoane, Itumeleng, Muhairwe, Josephine, Urda, Lorena, Amstutz, Alain, Tschumi , Nadine, Klimkait, Thomas, & Labhardt, Niklaus D. (2022). Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor- to dolutegravir-based antiretroviral therapy: a prospective cohort study in Lesotho (DO-REAL study). HIV medicine, 23(3), 287–293. https://doi.org/10.1111/hiv.13189